Implementation of capecitabine (Xeloda®) into a cancer centre: UK experience

This publication has 26 references indexed in Scilit:

• The vital role of education and information in patients receiving capecitabine (Xeloda®)
  European Journal of Oncology Nursing, 2004
• Patient Education: The Cornerstone of Successful Oral Chemotherapy Treatment
  Clinical Journal of Oncology Nursing, 2003
• A Changing Paradigm for Cancer Treatment: The Advent of New Oral Chemotherapy Agents
  Clinical Journal of Oncology Nursing, 2003
• 271 Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advance colorectal cancer
  European Journal of Cancer Supplements, 2003
• First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous5-fluorouracil/leucovorin
  Annals of Oncology, 2002
• Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study
  Journal of Clinical Oncology, 2001
• Reviewing audit: barriers and facilitating factors for effective clinical audit
  Quality and Safety in Health Care, 2000
• Implementing findings of research
  BMJ, 1994
• Infectious Complications of Indwelling Long-term Central Venous Catheters
  Chest, 1990
• Clinical Pharmacology of 5-Fluorouracil
  Clinical Pharmacokinetics, 1989